DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 55 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $8,978,000 | +0.2% | 175,000 | +16.7% | 0.07% | -13.0% |
| Q2 2020 | $8,958,000 | -64.7% | 150,000 | -75.7% | 0.08% | -71.7% |
| Q1 2020 | $25,371,000 | -14.3% | 616,261 | +29.6% | 0.27% | +5.4% |
| Q4 2019 | $29,594,000 | +185.0% | 475,484 | +55.4% | 0.26% | +177.4% |
| Q3 2019 | $10,385,000 | -66.7% | 305,978 | -62.0% | 0.09% | -64.9% |
| Q3 2018 | $31,170,000 | +33.2% | 805,004 | +35.4% | 0.26% | +87.9% |
| Q2 2018 | $23,396,000 | +747.7% | 594,551 | +331.8% | 0.14% | +403.6% |
| Q1 2018 | $2,760,000 | -51.3% | 137,700 | -44.9% | 0.03% | -51.7% |
| Q4 2017 | $5,668,000 | – | 250,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,086,723 | $85,910,000 | 25.70% |
| SV Health Investors, LLC | 449,951 | $18,525,000 | 15.54% |
| Redmile Group, LLC | 5,116,263 | $210,637,000 | 5.90% |
| Eversept Partners, LP | 414,081 | $17,047,715 | 4.24% |
| Sunesis Advisors, LLC | 96,299 | $3,965,000 | 3.99% |
| Avoro Capital Advisors LLC | 2,000,000 | $82,340,000 | 2.78% |
| Opaleye Management Inc. | 222,000 | $9,140,000 | 2.42% |
| SECTORAL ASSET MANAGEMENT INC | 204,059 | $8,401,000 | 1.61% |
| Artal Group S.A. | 800,000 | $32,936,000 | 1.39% |
| Atika Capital Management LLC | 141,000 | $5,805,000 | 1.11% |